CE Search Engine Logo

Applications of Neoantigens to Blood Malignancies

Access Activity

Overview / Abstract:

This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.
Educational Objectives

Upon completion of this activity, participants should be better able to:

Explain how neoantigen-directed immunotherapy enhances the anti-tumor immune response
Identify strategies to incorporate immunotherapy into the treatment of appropriate patients with hematologic malignancies on the basis of current guidelines, safety and efficacy, and expert advice

Expiration

Mar 26, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

.5

Accreditation

ACCME

Presenters / Authors / Faculty

Catherine J. Wu, MD

Professor of Medicine
Dana-Farber Cancer Institute and Harvard Medical School
Institute Member, Broad Institute of Harvard and MIT
Boston, MA

Activity Specialities / Related Topics

Hematology, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

Amgen Inc. and Celgene Corporation

Keywords / Search Terms

Relias LLC leukemia, blood, hematology, Neoantigens,Blood Malignancies Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map